Long-term prognosis after acute myocardial infarction in patients with a history of arterial hypertension

European Heart Journal

Volumn 19, Issue 4, 1998, Pages 588-594

  Gustafsson, F ^a,e   Kober L ^b   Torp Pedersen, C ^b   Hildebrandt, P ^a   Ottesen, M M ^c   Sonne, B ^b   Carlsen, J ^d  

^a FREDERIKSBERG HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^d Medicon Clinical Research   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Hypertension; Left ventricular function; Mortality; Myocardial infarction; Prognosis; Risk stratification

Indexed keywords

DIURETIC AGENT; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; DENMARK; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE;

AGE DISTRIBUTION; AGED; DENMARK; EVALUATION STUDIES; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0031965547     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1997.0822     Document Type: Article

References (30)

1. Lindblad U, Rastam L, Ranstam J. Acute myocardial infarction in patients treated for hypertension in the Skaraborg Hypertension Project. Eur Heart J 1993; 14: 291-6.
2. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. Arch Intern Med 1993; 153: 598-615.
3. Henning R, Wedel H. The long-term prognosis after myocardial infarction: a five-year follow-up study. Eur Heart J 1982; 2: 65-74.
4. Herlitz J, Karlson BW, Richter A, Wiklund O, Jablonskiene D, Hjalmarson A. Prognosis of hypertensives with acute myocardial infarction. J Hypertens 1992; 10: 1265-71.
5. Gottlieb S, Moss AJ, McDermott M, Eberly S. Deleterious effect of hypertension history on survival after myocardial infarction: relation to left ventricular ejection fraction and pulmonary congestion (Abstract). Circulation 1990; 82 (Suppl III): III-251.
6. Herlitz J, Bång A, Karlson BW. Five-year prognosis after acute myocardial infarction in relation to a history of hypertension. Am J Hypertens 1995; 9: 70-6.
7. Kannel WB. Role of blood pressure in cardiovascular morbidity and mortality. Prog Cardiovasc Dis 1974; 17: 5-24.
8. Kannel WB, Sorlie P, Castelli WP, McGee D. Blood pressure and survival after myocardial infarction: The Framingham study. Am J Cardiol 1980; 45: 326-30.
9. Rabkin SW, Mathewson FAL, Tate RB. Prognosis after acute myocardial infarction: Relation to blood pressure values before infarction in a prospective cardiovascular study. Am J Cardiol 1977; 40: 604-10.
10. Taylor GT, Humphries JO, Mellits ED et al. Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction. Circulation 1980; 62: 960-70.
11. Fresco C, Avanzi F, Bosi S et al. Prognostic value of a history of hypertension in 11 483 patients with myocardial infarction treated with thrombolysis. J Hypertens 1996; 14: 743-50.
12. White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RML, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987; 76: 44-51.
13. Gottlieb S, Moss MJ, McDermott M, Eberly S. Interrelation of left ventricular ejection fraction, pulmonary congestion and outcome in acute myocardial infarction. Am J Cardiol 1992; 69: 977-84.
14. The TRACE Study Group. The TRAndolapril Cardiac Evaluation (TRACE) Study: rationale, design, and baseline characteristics of the screened population. Am J Cardiol 1994; 73: 44C-50C.
15. Køber L, Torp-Pedersen C, Carlsen JE et al. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995; 333: 1670-6.
16. Køber L, Torp-Pedersen C, Carlsen J, Videbæk R, Egeblad H. An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study). Eur Heart J 1994; 15: 1616-20.
17. Volpi A, De Vita C, Franzosi MG et al. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. Circulation 1993; 88: 416-29.
18. Norris RM, Caughey DE, Mercer CJ, Scott PJ. Prognosis after myocardial infarction. Six year follow-up. Br Heart J 1974; 36: 786-90.
19. Martin CA, Thompson PL, Armstrong BK, Hobbs MST, De Klerk N. Long-term prognosis after recovery from myocardial infarction: a nine-year follow-up of the Perth coronary register. Circulation 1983; 68: 961-9.
20. Gruppo Italiano per lo Studio della Soprawivenza nell'infarto Miocardio. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343: 1115-22.
21. Devereux RB, Roman MJ. Interrelationships between hypertension, left ventricular hypertrophy and coronary heart disease. J Hypertens 1993; 11: S3-S9.
22. Motz W, Vogt M, Scheler S, Schwarzkopff B, Strauer BE. Coronary circulation in arterial hypertension. J Cardiovasc Pharmacol 1991; 17: S35-S39.
23. Strauer B-E. Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol 1979; 44: 999-1066.
24. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990; 322: 1561-6.
25. Dunn FG, McLenahan J, Isles CG et al. Left ventricular hypertrophy and mortality in hypertension: an analysis of data from the Glasgow Blood Pressure Clinic. J Hypertens 1990; 8: 775-82.
26. Messerli FH, Grodzicki T. Hypertension, left ventricular hypertrophy, ventricular arrhythmias and sudden death. Eur Heart J 1992; 13 (Suppl D): 66-9.
27. Piérard LA, Albert A, Gilis F, Sprynger M, Carlier J, Kulbertus HE. Hemodynamic profile of patients with acute myocardial infarction at risk of infarct expansion. Am J Cardiol 1987; 60: 5-9.
28. Pfeffer MA, Braunwald E. Ventricular remodelling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990; 81: 1161-72.
29. Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-5.
30. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly programme (SHEP). JAMA 1991; 265: 3255-64.